SynthesisJournal of cancer research and clinical oncology2009

Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis.

Josh John Carlson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.